Sequence engineering to reduce the viscosity of high concentration mAb formulations

Original language	English
Publication status	Published - 14 Oct 2023
Event	BioProNET 2023 - Stevenage, United Kingdom Duration: 14 Oct 2023 → 14 Oct 2023

Conference

Conference	BioProNET 2023
Country/Territory	United Kingdom
City	Stevenage
Period	14/10/23 → 14/10/23

Keywords

• biologics
• antibody
• developability
• manufacture
• prediction

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

• 

Projects

• 1 Finished

Projects per year

• Sequence engineering to improve the performance of biopharma in patient administration syringe devices

  Rattray, Z. (Principal Investigator), Jamieson, C. (Principal Investigator) & Armstrong, G. (Post Grad Student)

  1/10/21 → 30/09/24

  Project: Research - Studentship

  • Immunoglobulin G 100%
  • Intravenous Immunoglobulin 50%
  • Immunoglobulin G3 50%
  • Monoclonal Antibody 46%
  • Solution and Solubility 16%

Cite this

• APA
• Author
• BIBTEX
• Harvard
• Standard
• RIS
• Vancouver

Rattray, Z., Lewis, W., & Armstrong, G. (2023). Sequence engineering to reduce the viscosity of high concentration mAb formulations. BioProNET 2023, Stevenage, United Kingdom.

Rattray, Zahra ; Lewis, Will ; Armstrong, Georgina. / Sequence engineering to reduce the viscosity of high concentration mAb formulations. BioProNET 2023, Stevenage, United Kingdom.

@conference{67454137961342db8bdf5e533701d138,

title = "Sequence engineering to reduce the viscosity of high concentration mAb formulations",

keywords = "biologics, antibody, developability, manufacture, prediction",

author = "Zahra Rattray and Will Lewis and Georgina Armstrong",

year = "2023",

month = oct,

day = "14",

language = "English",

note = "BioProNET 2023 ; Conference date: 14-10-2023 Through 14-10-2023",

}

Rattray, Z, Lewis, W & Armstrong, G 2023, 'Sequence engineering to reduce the viscosity of high concentration mAb formulations', BioProNET 2023, Stevenage, United Kingdom, 14/10/23 - 14/10/23.

Sequence engineering to reduce the viscosity of high concentration mAb formulations. / Rattray, Zahra; Lewis, Will; Armstrong, Georgina.
2023. BioProNET 2023, Stevenage, United Kingdom.

Research output: Contribution to conference › Presentation/Speech

TY - CONF

T1 - Sequence engineering to reduce the viscosity of high concentration mAb formulations

AU - Rattray, Zahra

AU - Lewis, Will

AU - Armstrong, Georgina

PY - 2023/10/14

Y1 - 2023/10/14

KW - biologics

KW - antibody

KW - developability

KW - manufacture

KW - prediction

M3 - Presentation/Speech

T2 - BioProNET 2023

Y2 - 14 October 2023 through 14 October 2023

ER -

Rattray Z, Lewis W, Armstrong G. Sequence engineering to reduce the viscosity of high concentration mAb formulations. 2023. BioProNET 2023, Stevenage, United Kingdom.